Israeli researcher receives EU grant for development of 'electronic nose'

An Israeli researcher has been awarded a grant of € 1.73 million by the EU under its Marie Curie Excellence programme for the development of an 'electronic nose' that can sniff out cancer.

Dr Hossam Haick of the Israel Institute of Technology received the award as part of the EU's efforts to strengthen and encourage young promising scientists.

Dr Haick is 31 years old and also the recipient of the largest grant ever received from the EU by an Israeli researcher. He will be working on artificial olfactory systems or 'electronic noses' aimed at sniffing out and diagnosing cancer at the earliest possible stage before it spreads.

"Realisation of the research goal will enable creating an instrument based on nanometre-sized sensors that can diagnose different cancers and even determine at what stage the disease is," explains Dr Haick. "The diagnosis can be carried out at a very early stage even before the tumour has begun to spread. Thus, treatment will be immediate and will destroy the disease at its inception."

Electronic noses are one example of a growing research area called biomimetics, or biomimicry, which involves human-made applications patterned on natural phenomena.

As an odour is composed of molecules, each of which has a specific size and shape, each of these molecules has a receptor of a corresponding size and shape in the human nose. When a specific receptor receives a molecule, it sends a signal to the brain and the brain identifies the smell associated with that particular molecule. Electronic noses based on the biological model work in a similar manner, substituting sensors for the receptors, and transmitting the signal to a program for processing, instead of the brain.

Dr Haick intends to develop sensor arrays made of nanomaterials, understanding the fundamental chemical, physical, and electrical properties of these nanomaterials and the signal mechanism of these sensors.

He will also be developing the smallest versions of these electronic noses; the 'e-nose on chip', which is a single computer chip containing both the sensors and the processing components.

In addition, to targeting the early diagnosis, detection and screening of a disease, artificial olfactory systems are used in environmental-monitoring, the food industries and security.

For further information, please visit: Technion - Israel Institute of Technology

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

First Virtual DMEA to Open with a Wide R…

16 - 18 June 2020, Berlin, Germany. Under the heading 'DMEA sparks' and taking place for the first time, this year's DMEA is an entirely virtual event. From 16 to 18...

Philips Launches HealthSuite Clinical Tr…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Clinical Trial Accelerator on Philips HealthSuite. This new tailored set of capabilities allows life science organizations to...

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...

WiFi SPARK Works with Visionable to Conn…

Seven NHS Trusts are using technology developed by WiFi SPARK in response to an urgent request from leading NHS Trusts to find a way to connect hospital patients with their...

Digital Contact Tracing for COVID-19: An…

An article in CMAJ (Canadian Medical Association Journal) analyzes the strengths and limitations of digital contact tracing for people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to help...